Study reveals genetic mutations associated with aggressive prostate cancer
Aggressive prostate cancer accounts for up to 15% of all prostate cancer diagnoses
Read More
Tag: UK Genetic Prostate Cancer Study
- Nuclera and leadXpro partner to accelerate structure‑based drug design
- Lundbeck reports positive phase 2b results for migraine prevention drug
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
